Atrial Fibrillation.

Area of Science:

• Cardiology
• Geriatric Medicine
• Clinical Electrophysiology

Background:

• Atrial fibrillation (AF) is a growing global health concern, particularly with increasing elderly populations and longevity.
• The arrhythmia presents with diverse clinical manifestations, ranging from asymptomatic to severely symptomatic and paroxysmal to permanent forms.
• Major risks associated with AF include stroke and mortality, necessitating effective management strategies.

Purpose of the Study:

• To review the current challenges in managing atrial fibrillation (AF).
• To discuss the primary risks of AF, including stroke and death.
• To evaluate the role of current pharmacologic and emerging nonpharmacologic therapies in AF management.

Main Methods:

• Review of current clinical practices and therapeutic approaches for atrial fibrillation (AF).
• Analysis of the efficacy of pharmacologic treatments, focusing on anticoagulation for stroke prevention.
• Examination of ongoing basic and clinical research into nonpharmacologic interventions for AF.

Main Results:

• Current therapies primarily focus on symptom management and stroke prevention through anticoagulation.
• The benefit of AF prevention on overall survival has not yet been definitively established.
• Nonpharmacologic therapies are under active investigation as potentially superior methods for improving patient outcomes.

Conclusions:

• Atrial fibrillation (AF) management is a critical challenge, especially in aging populations.
• While anticoagulation is essential for preventing thromboembolic complications, its impact on survival is unproven.
• Nonpharmacologic treatments represent a promising frontier for enhancing the care and outcomes of patients with atrial fibrillation.